The PBS takes a clear step in this direction, with the combination of SGLT-2 inhibitors and metformin now being the initial choice of treatment in people with type 2 diabetes and established CV disease, at high risk of a CV event, or in those of Aboriginal or Torres Strait Islander origin
Houtkooper, R.) 105138 (Sirtuins, 2016)
In clinics and the wider literature it is studied and marketed for fat metabolism and weight support , because each nutrient has a documented role in how the liver processes and exports fat
What factors should providers consider when prescribing GLP-1 agonists to patients, and how can their medical history, such as pregnancy or concurrent medications, influence the treatment plan
Peptides may be considered as part of a broader treatment approach that includes nutrition, physical activity, and medical evaluation
CrossRef Scars of oxidative stress: protein carbonylation and beta cell dysfunction in diabetes Ashley Ling, Katherine R